Skip to main content
Premium Trial:

Request an Annual Quote

Decode Shares Hit 52-Week High on Diabetes Gene Discovery

NEW YORK, Jan. 17 (GenomeWeb News) - Shares of Decode Genetics hit a 52-week high in trading today after the company's weekend announcement that it had discovered a variation of a gene that heightens the risk of type 2 diabetes.


Decode's stock price rose $1.39, or almost 15 percent, to a high of $10.77 in morning trading before retreating back below $10. The shares were trading up 5.97 percent, or $.56, at $9.94 in late-afternoon trading.


On Sunday the Reykjavik-based company said it had discovered a variant in a gene on chromosome 10 that raises the risk of adult onset diabetes.

The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.